BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27493623)

  • 41. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.
    Liedtke C; Thill M; Hanf V; Schütz F;
    Breast Care (Basel); 2014 Jul; 9(3):189-200. PubMed ID: 25177261
    [No Abstract]   [Full Text] [Related]  

  • 42. Radiotherapy for patients with unresected locally advanced breast cancer.
    Yee C; Alayed Y; Drost L; Karam I; Vesprini D; McCann C; Soliman H; Zhang L; Chow E; Chan S; Lee J
    Ann Palliat Med; 2018 Oct; 7(4):373-384. PubMed ID: 30180725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)].
    Fourquet A; Cutuli B; Luporsi E; Mauriac L; Garbay JR; Giard S; Spyratos F; Sigal-Zafrani B; Dilhuydy JM; Acharian V; Balu-Maestro C; Blanc-Vincent MP; Cohen-Solal C; De Lafontan B; Dilhuydy MH; Duquesne B; Gilles R; Lesur A; Shen N; Cany L; Dagousset I; Gaspard MH; Hoarau H; Hubert A; Monira MH; Perrié N; Romieu G
    Cancer Radiother; 2002 Jun; 6(4):238-58. PubMed ID: 12224489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for brain relapse in HER2-positive metastatic breast cancer patients.
    Duchnowska R; Dziadziuszko R; Czartoryska-Arłukowicz B; Radecka B; Szostakiewicz B; Sosińska-Mielcarek K; Karpińska A; Starosławska E; Kubiatowski T; Szczylik C
    Breast Cancer Res Treat; 2009 Sep; 117(2):297-303. PubMed ID: 19130219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors.
    Pisansky TM; Ingle JN; Schaid DJ; Hass AC; Krook JE; Donohue JH; Witzig TE; Wold LE
    Cancer; 1993 Aug; 72(4):1247-60. PubMed ID: 8339215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
    Leccia MT; Planchamp F; Sassolas B; Combemale P; Modiano P; Bedane C; Cupissol D; Derrey S; Dygai-Cochet I; Lamant L; Lubrano V; Mirabel X; Mourrégot A; Rougé Bugat ME; Siegrist S; Thariat J; Tiffet O; Truc G; Verdoni L; Mazeau-Woynar V
    Ann Dermatol Venereol; 2014 Feb; 141(2):111-21. PubMed ID: 24507205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer.
    Miller K; Cortes J; Hurvitz SA; Krop IE; Tripathy D; Verma S; Riahi K; Reynolds JG; Wickham TJ; Molnar I; Yardley DA
    BMC Cancer; 2016 Jun; 16():352. PubMed ID: 27259714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemma.
    Deo SV; Purkayastha J; Shukla NK; Raina V; Asthana S; Das DK; Rath GK
    J Assoc Physicians India; 2003 Mar; 51():272-5. PubMed ID: 12839350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics.
    Lüftner D; Schneeweiss A; Hartkopf AD; Müller V; Wöckel A; Janni W; Ettl J; Belleville E; Schütz F; Thill M; Huober J; Fasching PA; Kolberg HC; Pöschke P; Welslau M; Overkamp F; Tesch H; Fehm TN; Lux MP
    Geburtshilfe Frauenheilkd; 2020 Apr; 80(4):391-398. PubMed ID: 32322108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging diagnosis of metastatic breast cancer.
    Pesapane F; Downey K; Rotili A; Cassano E; Koh DM
    Insights Imaging; 2020 Jun; 11(1):79. PubMed ID: 32548731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiological Staging for Distant Metastases in Breast Cancer Patients with Confirmed Local and/or Locoregional Recurrence: How Useful are Current Guideline Recommendations?
    Elfgen C; Schmid SM; Tausch CJ; Montagna G; Güth U
    Ann Surg Oncol; 2019 Oct; 26(11):3455-3461. PubMed ID: 31332637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse].
    Compagnon F; Zerdoud S; Rives M; Laprie A; Sarini J; Grunenwald S; Chaltiel L; Graff P
    Cancer Radiother; 2016 Jul; 20(5):362-9. PubMed ID: 27396902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of liver dominant metastatic breast cancer: surgery, chemotherapy, or hepatic arterial therapy - benefits and limitations.
    Rodes Brown S; Martin RC
    Minerva Chir; 2012 Aug; 67(4):297-308. PubMed ID: 23022754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer.
    Mignot F; Loirat D; Dureau S; Bataillon G; Caly M; Vincent-Salomon A; Berger F; Fourquet A; Pierga JY; Kirova YM; Bidard FC
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):389-396. PubMed ID: 30291993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation].
    Loganadane G; Xi Z; Fournier-Bidoz N; Xu HP; Grellier Adedjouma N; Bazire L; Fourquet A; Kirova YM
    Cancer Radiother; 2019 Feb; 23(1):38-45. PubMed ID: 30595340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
    Huang L; Chen S; Yang WT; Shao Z
    Oncotarget; 2017 Jun; 8(24):39703-39710. PubMed ID: 28055977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy observation of (125)I seed implantation therapy for locoregional recurrent and metastatic breast cancer].
    Yi FX; Yu YH; Wei CY; Yang WP; Qin QH; Tan QX; Mo QG; Huang Z; Lian B
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):472-5. PubMed ID: 27346407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NCCN Guidelines Update: Breast Cancer.
    Gradishar W; Salerno KE
    J Natl Compr Canc Netw; 2016 May; 14(5 Suppl):641-4. PubMed ID: 27226503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cancer of the breast: results and toxicity of locoregional irradiation after mastectomy].
    Cutuli B
    Cancer Radiother; 2000 Nov; 4 Suppl 1():167s-179s. PubMed ID: 11194957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.